One Stop Systems, Inc. (OSS or the Company) (NASDAQ:OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced a new $2 million production contract from a breakthrough medical imaging OEM advancing non-invasive breast cancer screening. OSS expects the total program value of at least $25 million over the next five years.

Under the terms of the contract, OSS will provide 65 next-generation liquid-cooled 3U-SDS that have become standard on all the OEM's Breast Scanning devices. OSS expects to recognize revenue from this contract over the next six to twelve months. This order represents a transition from successful pilot to volume production, following an initial $500,000 development-phase order in March 2025.